The association between circulating lipoprotein subfractions and lipid content in coronary atheromatous plaques assessed by near-infrared spectroscopy

Bibliographic Details
Title: The association between circulating lipoprotein subfractions and lipid content in coronary atheromatous plaques assessed by near-infrared spectroscopy
Authors: Julie Caroline Sæther, Elisabeth Kleivhaug Vesterbekkmo, Bruna Gigante, Guro Fanneløb Giskeødegård, Tone Frost Bathen, Turid Follestad, Rune Wiseth, Erik Madssen, Anja Bye
Source: International Journal of Cardiology: Heart & Vasculature, Vol 46, Iss , Pp 101215- (2023)
Publisher Information: Elsevier, 2023.
Publication Year: 2023
Collection: LCC:Diseases of the circulatory (Cardiovascular) system
Subject Terms: NIRS, maxLCBI4mm, Coronary atherosclerosis, NMR spectroscopy, Lp(a), HDL subfractions, Diseases of the circulatory (Cardiovascular) system, RC666-701
More Details: Background: Lipid content in coronary atheromatous plaques, measured by near-infrared spectroscopy (NIRS), can predict the risk of future coronary events. Biomarkers that reflect lipid content in coronary plaques may therefore improve coronary artery disease (CAD) risk assessment. Purpose: We aimed to investigate the association between circulating lipoprotein subfractions and lipid content in coronary atheromatous plaques in statin-treated patients with stable CAD undergoing percutaneous coronary intervention. Methods: 56 patients with stable CAD underwent three-vessel imaging with NIRS when feasible. The coronary artery segment with the highest lipid content, defined as the maximum lipid core burden index within any 4 mm length across the entire lesion (maxLCBI4mm), was defined as target segment. Lipoprotein subfractions and Lipoprotein a (Lp(a)) were analyzed in fasting serum samples by nuclear magnetic resonance spectroscopy and by standard in-hospital procedures, respectively. Penalized linear regression analyses were used to identify the best predictors of maxLCBI4mm. The uncertainty of the lasso estimates was assessed as the percentage presence of a variable in resampled datasets by bootstrapping. Results: Only modest evidence was found for an association between lipoprotein subfractions and maxLCBI4mm. The lipoprotein subfractions with strongest potential as predictors according to the percentage presence in resampled datasets were Lp(a) (78.1 % presence) and free cholesterol in the smallest high-density lipoprotein (HDL) subfractions (74.3 % presence). When including established cardiovascular disease (CVD) risk factors in the regression model, none of the lipoprotein subfractions were considered potential predictors of maxLCBI4mm. Conclusion: In this study, serum levels of Lp(a) and free cholesterol in the smallest HDL subfractions showed the strongest potential as predictors for lipid content in coronary atheromatous plaques. Although the evidence is modest, our study suggests that measurement of lipoprotein subfractions may provide additional information with respect to coronary plaque composition compared to traditional lipid measurements, but not in addition to established risk factors. Further and larger studies are needed to assess the potential of circulating lipoprotein subfractions as meaningful biomarkers both for lipid content in coronary atheromatous plaques and as CVD risk markers.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2352-9067
Relation: http://www.sciencedirect.com/science/article/pii/S2352906723000465; https://doaj.org/toc/2352-9067
DOI: 10.1016/j.ijcha.2023.101215
Access URL: https://doaj.org/article/c448cd50064e41af9c19be1a3593752e
Accession Number: edsdoj.448cd50064e41af9c19be1a3593752e
Database: Directory of Open Access Journals
More Details
ISSN:23529067
DOI:10.1016/j.ijcha.2023.101215
Published in:International Journal of Cardiology: Heart & Vasculature
Language:English